News & Events Year None2022202120202019201820172016201520142013201220112009 02/22/22 REGENXBIO to Host Conference Call on March 1 to Discuss Fourth Quarter and Full-Year 2021 Financial Results and Recent Operational Highlights 02/12/22 REGENXBIO Presents Positive Interim Data from Phase II ALTITUDE™ Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery 02/09/22 REGENXBIO Presents Positive Initial Data from Phase I/II Trial of RGX-111 for the Treatment of Severe MPS I at 18th Annual WORLDSymposium™ 2022 02/09/22 REGENXBIO Presents Additional Positive Interim Data from Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at 18th Annual WORLDSymposium™ 2022 02/08/22 REGENXBIO Announces Presentations at the 11th Annual SVB Leerink Global Healthcare Conference 02/04/22 REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2022 Conference 01/31/22 REGENXBIO Announces Presentations at the 18th Annual WORLDSymposium™ 2022 Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Next page next › Last page last »
